These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 22607913)
1. The inhibition of tumor growth and metastasis by self-assembled nanofibers of taxol. Wang H; Wei J; Yang C; Zhao H; Li D; Yin Z; Yang Z Biomaterials; 2012 Aug; 33(24):5848-53. PubMed ID: 22607913 [TBL] [Abstract][Full Text] [Related]
2. Enzyme-instructed molecular self-assembly confers nanofibers and a supramolecular hydrogel of taxol derivative. Gao Y; Kuang Y; Guo ZF; Guo Z; Krauss IJ; Xu B J Am Chem Soc; 2009 Sep; 131(38):13576-7. PubMed ID: 19731909 [TBL] [Abstract][Full Text] [Related]
3. Disulfide bond reduction-triggered molecular hydrogels of folic acid-Taxol conjugates. Yang C; Li D; Fengzhao Q; Wang L; Wang L; Yang Z Org Biomol Chem; 2013 Sep; 11(40):6946-51. PubMed ID: 23989242 [TBL] [Abstract][Full Text] [Related]
4. [Comparative studies of paclitaxel injection "SAWAI" and Taxol® Injection on pharmacokinetics in dogs and in vitro/vivo antitumor activities]. Takahashi M; Hosoda M; Takahashi H; Todo S Gan To Kagaku Ryoho; 2010 Sep; 37(9):1699-706. PubMed ID: 20841931 [TBL] [Abstract][Full Text] [Related]
5. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789 [TBL] [Abstract][Full Text] [Related]
6. Antitumor efficacy of solid dispersion of paclitaxel prepared by supercritical antisolvent process in human mammary tumor xenografts. Shanmugam S; Park JH; Chi SC; Yong CS; Choi HG; Woo JS Int J Pharm; 2011 Jan; 403(1-2):130-5. PubMed ID: 20974239 [TBL] [Abstract][Full Text] [Related]
7. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. Obara K; Ishihara M; Ozeki Y; Ishizuka T; Hayashi T; Nakamura S; Saito Y; Yura H; Matsui T; Hattori H; Takase B; Ishihara M; Kikuchi M; Maehara T J Control Release; 2005 Dec; 110(1):79-89. PubMed ID: 16289419 [TBL] [Abstract][Full Text] [Related]
8. Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy. Sharma D; Chelvi TP; Kaur J; Chakravorty K; De TK; Maitra A; Ralhan R Oncol Res; 1996; 8(7-8):281-6. PubMed ID: 8938791 [TBL] [Abstract][Full Text] [Related]
9. Toxicity studies of cremophor-free paclitaxel solid dispersion formulated by a supercritical antisolvent process. Park JH; Chi SC; Lee WS; Lee WM; Koo YB; Yong CS; Choi HG; Woo JS Arch Pharm Res; 2009 Jan; 32(1):139-48. PubMed ID: 19183887 [TBL] [Abstract][Full Text] [Related]
10. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643 [TBL] [Abstract][Full Text] [Related]
11. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Gong C; Wang C; Wang Y; Wu Q; Zhang D; Luo F; Qian Z Nanoscale; 2012 May; 4(10):3095-104. PubMed ID: 22535210 [TBL] [Abstract][Full Text] [Related]
12. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients. Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ Cancer Chemother Pharmacol; 2009 May; 63(6):1049-63. PubMed ID: 18791718 [TBL] [Abstract][Full Text] [Related]
13. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion. Liu X; Sun J; Chen X; Wang S; Scott H; Zhang X; Zhang Q J Pharm Pharmacol; 2012 Jun; 64(6):775-82. PubMed ID: 22571255 [TBL] [Abstract][Full Text] [Related]
15. Short-peptide-based molecular hydrogels: novel gelation strategies and applications for tissue engineering and drug delivery. Wang H; Yang Z Nanoscale; 2012 Sep; 4(17):5259-67. PubMed ID: 22814874 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel delivery to brain tumors from hydrogels: a computational study. Torres AJ; Zhu C; Shuler ML; Pannullo S Biotechnol Prog; 2011; 27(5):1478-87. PubMed ID: 21786432 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666 [TBL] [Abstract][Full Text] [Related]
18. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma. Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646 [TBL] [Abstract][Full Text] [Related]
20. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis. Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]